Please select a region
Manage Consent Preferences
Cookie Details
Strictly Functional Cookie
Analytics Cookie
Targeting Cookie
Back
Analytics Cookies
x
Cookies List
Our site is undergoing a scheduled maintenance from 30th December 2020 to 3rd January 2021 and some functionalities will not be available at this time
Loading your cart..
-
Products
Products
-
Services
Services
-
-
Challenges
Challenges
-
Reducing Total Cost of Ownership
Solving the Challenge of High pH Injectable Drug ProductsClick HerePackaging Solutions for Sensitive Molecules
Solving the Challenge of Single-Use Large-Volume Delivery for Patient Self-Injection
-
-
Support
Support
-
Regulatory SupportWest Regulatory Affairs provides a single point of contact to assist with global registration strategies for all West products and processes.Regulatory SupportKnowledge CenterThe West Knowledge Center provides scientific insight and more detailed technical information on key areas of expertise featuring technical reports, bulletins and science posters.Knowledge Center
-
Services
Challenges

Solving the Challenge of High pH Injectable Drug Products
Click Here

Solving the Challenge of Single-Use Large-Volume Delivery for Patient Self-Injection
Support
Regulatory Support
West Regulatory Affairs provides a single point of contact to assist with global registration strategies for all West products and processes.
Regulatory Support
Knowledge Center
The West Knowledge Center provides scientific insight and more detailed technical information on key areas of expertise featuring technical reports, bulletins and science posters.
Knowledge Center
Latest Post
June 26, 2020
Performance of AccelTRA® Components
To improve the consistent evaluation of the quality and efficacy of generic drugs for injections, National Medical Products Administration of China(NMPA)published the draft guidance “<em>Technical Requirement for Quality and Efficacy Consistency Evaluation on Chemical Generic Injections (Exposure Draft)</em>” (15 October 2019). This indicates that the evaluation of the consistency of injections has finally begun. This Exposure Draft clarifies the specific technical requirements on reference-listed drugs, prescription technology, quality control of bulk drugs and excipient packaging, quality studies and control, stability studies, etc.
Previous Posts

July 10, 2019
Intended Use and Packaging Risks for Compounding Pharmacies (503Bs)

Amy Kim
Sr. Specialist, Scientific Communications, SA & TS

January 29, 2019
Effective Drug Protection for Plungers in a Prefillable Syringe System

Christa Jansen-Otten
Director, Product Mgmt, PFS & Delivery

May 01, 2018
Addressing the Complexities of Ophthalmic Drug Delivery

Susan Dounce
Principal SME, Prefilled Syringes, Crystal Zenith, Combination Products

September 28, 2017
Controlling Particle Load in NovaPure® Elastomer Components

Page McAndrew
Director, Scientific Communications, Scientific Affairs & TCS

September 25, 2017
When Silicone Oil Is Not an Option

Dr. Birgit Müller-Chorus
Principal Technical Subject Matter Expert PFS, TCS
Load more
Loading...